{"denomUnitsSelected":"Participants","description":"According to the International Myeloma Working Group (IMWG) Uniform Response Criteria for Multiple Myeloma:\n\nProgression Free Survival (PFS)-Time from P-BCMA-101 treatment to progressive disease.","reportingStatus":"NOT_POSTED","timeFrame":"Baseline through Month 24","title":"Phase 2: Evaluate Efficacy Endpoints (PFS)","type":"SECONDARY"}